Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine if treatment with Ramelteon will help to improve
insomnia in older adults with co-existent insomnia and sleep apnea. The primary study
objective is sleep latency (a measure of insomnia). The hypothesis is that sleep latency will
be reduced in subjects taking Ramelteon relative to the placebo arm. The secondary study
objective is to determine if subject compliance with CPAP treatment of their sleep apnea is
improved in subjects taking Ramelteon (their compliance may be improved because they would
have less insomnia due to Ramelteon treatment when using their CPAP). The hypothesis is that
compliance with CPAP will be improved in subjects taking Ramelteon relative to the placebo
arm.